CytoDyn CYDY
OTC CYDY
$0.23 +0.00 (+0.00%)
At close: Nov 11, 2026 · 4:00 PM EST

CytoDyn (CYDY) Selling, General & Administrative (2009 - 2026)

Updated

CytoDyn (CYDY) reported Selling, General & Administrative of $2.06 million for fiscal Q1 2027 (quarter ended Aug 31, 2026), up 20.0% from $1.71 million a year earlier but down 9.9% from the prior quarter.

Analysis

CytoDyn (CYDY) Selling, General & Administrative (2009 - 2026) Analysis & Trends

Over the twelve months ended Aug 31, 2026, CytoDyn's Selling, General & Administrative came in at $7.79 million, up 5.8% year-over-year; for FY2026 (ended May 31, 2026), it was $7.45 million, up 2.6% from FY2025.

  • Selling, General & Administrative has a five-year compound annual growth rate of -26.3% (FY2021 to FY2026).
  • By fiscal year, Selling, General & Administrative came in at $7.26 million in FY2025 (-32.9%), $10.82 million in FY2024 (-36.9%), $17.14 million in FY2023 (-61.3%) and $44.3 million in FY2022 (+29.1%).
  • Five-year quarterly Selling, General & Administrative spans a low of $1.52 million in fiscal Q3 2025 and a high of $16.2 million in fiscal Q2 2022.
  • Year over year, Selling, General & Administrative has now increased in each of the last three quarters, with an average decline of 5.9% over the last eight quarters.
  • The high point for year-over-year Selling, General & Administrative in five years was fiscal Q2 2022 (growth of 114.6%); the low point was fiscal Q4 2023 (a decline of 73.0%).
  • Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $2.28 million (Q4 2026), $1.65 million (Q3 2026) and $1.8 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 3.13 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 6.29 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 4.09 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.89 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 5.11 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.68 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.64 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 3.28 Bn
10 CytoDyn 334.50 Mn 285.65 Mn - 2.06 Mn
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2026 2.06 Mn
May 31, 2026 2.28 Mn
Feb 28, 2026 1.65 Mn
Nov 30, 2025 1.80 Mn
Aug 31, 2025 1.71 Mn
May 31, 2025 1.84 Mn
Feb 28, 2025 1.52 Mn
Nov 30, 2024 2.30 Mn
Aug 31, 2024 1.61 Mn
May 31, 2024 3.06 Mn
Feb 29, 2024 2.76 Mn
Nov 30, 2023 2.31 Mn
Aug 31, 2023 2.69 Mn
May 31, 2023 2.79 Mn
Feb 28, 2023 2.97 Mn
Nov 30, 2022 5.04 Mn
Aug 31, 2022 6.33 Mn
May 31, 2022 10.34 Mn
Feb 28, 2022 10.14 Mn
Nov 30, 2021 16.20 Mn
API Access

CytoDyn Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CYDY&period=max&api_key=YOUR_API_KEY